Colonization of the gastrointestinal tract with multidrug-resistant (MDR) bacteria is a consequence of gut dysbiosis. We describe the successful utilization of fecal microbiota transplantation to inhibit Klebsiella pneumoniae MBL(+) and Escherichia coli ESBL(+) gut colonization in the immunocompromised host as a novel tool in the battle against MDR microorganisms. ClinicalTrials.gov identifier NCT02461199.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4863031 | PMC |
| http://dx.doi.org/10.1007/s00005-016-0387-9 | DOI Listing |
Publication Analysis
Top Keywords
fecal microbiota
8
microbiota transplantation
8
immunocompromised host
8
transplantation inhibits
4
inhibits multidrug-resistant
4
multidrug-resistant gut
4
gut pathogens
4
pathogens preliminary
4
preliminary report
4
report performed
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!